Innovation Articles. App Notes, Case Studies. & White Papers

  1. Resolving In-Vitro Diagnostic Supply Chain Constraints 9/27/2026

    Explore strategies for securing recombinant proteins while addressing supply continuity, batch consistency, scale-up challenges, and quality requirements for clinical validation and commercialization.

  2. Transgenic Fruit Flies vs. Cell Lines: Eliminating Bioreactor Bottlenecks 9/26/2026

    Overcome biomanufacturing tradeoffs with expression strategies that enhance stability, scalability, and production consistency.

  3. Beyond The Bioreactor Scaling CGT Ancillary Materials With The EntoEngineā„¢ 9/26/2026

    Growing demand for cell and gene therapies is increasing pressure on cytokine production. Explore interleukin manufacturing, quality, consistency, safety, scalability, and supply reliability.

  4. From Sequence To Scale In Seven Months 9/26/2026

    Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.

  5. Manufacturing Glycosylated Erythropoietin Without š¯›¼1,3-Fucosylation 9/26/2026

    See how expression hosts affect recombinant EPO glycosylation, bioactivity, and consistency, with reproducible N-glycan profiles and absence of α1,3-linked fucosylation.

  6. Characterization Of Fly-Derived Prolactin: Insights Into Glycosylation And Activity 9/26/2026

    Explore how D. mel-derived human prolactin (hPRL) compares with hPRL expressed in E. coli and HEK293 cells through detailed physico-chemical and biological characterization.

  7. Exploring The Genetic Tools Enabling Protein Expression In Fruit Flies 9/26/2026

    Fruit fly genetics enables precise, scalable protein expression through stable integration, targeted control, inducible regulation, and heritable systems.

  8. The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins 9/26/2026

    Protein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.

  9. The Continuing Challenge Of Drug-Induced Liver Injury 9/24/2026

    Recent liver safety concerns highlight the limits of conventional preclinical testing. Human-relevant models could help researchers detect drug-induced liver injury earlier and reduce costly setbacks.

  10. Characterization Of Tumor-Specific T-Cells With Modifications 9/2/2026

    Explore a scalable RNA-seq approach that delivers reproducible, high-quality transcriptomic data from checkpoint-edited T-cells, uncovering gene expression changes linked to PD-1 and TIGIT deletion.